News Chart MoonLake Immunotherapeutics

Equities

MLTX

KY61559X1045

Market Closed - Nasdaq Other stock markets 01:30:00 19/06/2024 am IST			5-day change	1st Jan Change
39.49 ^USD	-1.69%		-8.80%	-34.61%

10/06	MoonLake Immunotherapeutics Announces Positive Regulatory Feedback from Both FDA and EMA on Path for the Phase 3 Program for the Nanobody Sonelokimab in Psoriatic Arthritis	CI
07/05	MoonLake Immunotherapeutics Q1 Net Loss Widens	MT

db480621181ffaadf94ac4832.-GJt2HoIjG8UH5f9BM2OkNGNsybtfVSVWpElHdvD_l4.vy8E4R1O6QJ7fOaZU6r52LS451-hHiDZHs5ES7izmDygCyGyDHq5WHtR-A~c2290eddc6d2fd912c9ac98af022954d